Loading...
XNYS
MCK
Market cap92bUSD
Jul 09, Last price  
792.81USD
1D
-3.16%
1Q
-8.41%
Jan 2017
464.48%
Name

Mckesson Corp

Chart & Performance

D1W1MN
XNYS:MCK chart
P/E
19.49
P/S
0.23
EPS
40.67
Div Yield, %
0.39%
Shrs. gr., 5y
-5.03%
Rev. gr., 5y
11.11%
Revenues
403.43b
+12.36%
92,977,000,000101,703,000,000106,632,000,000108,702,000,000112,084,000,000122,734,000,000122,455,000,000137,609,000,000179,045,000,000190,884,000,000198,533,000,000208,357,000,000214,319,000,000231,051,000,000238,228,000,000263,966,000,000276,711,000,000308,951,000,000359,051,000,000403,430,000,000
Net income
4.76b
+44.52%
963,000,000990,000,000823,000,0001,263,000,0001,130,000,0001,403,000,0001,338,000,0001,263,000,0001,476,000,0002,258,000,0005,183,000,00067,000,00034,000,000900,000,000-4,539,000,0001,114,000,0003,560,000,0003,002,000,0003,295,000,0004,762,000,000
CFO
6.16b
+1.15%
1,539,000,000869,000,0001,351,000,0002,316,000,0002,338,000,0002,950,000,0002,483,000,0003,136,000,0003,112,000,0003,672,000,0004,744,000,0004,345,000,0004,036,000,0004,374,000,0004,542,000,0004,434,000,0005,159,000,0004,314,000,0006,085,000,0006,155,000,000
Dividend
Dec 01, 20250.82 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

McKesson Corporation functions as a prominent global provider of healthcare services, serving markets within the United States and across various international regions. Its extensive operations are organized into four principal operating segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical division is responsible for the widespread distribution of a diverse range of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, as well as various other healthcare commodities. This segment additionally furnishes critical support, encompassing practice management, technological aid, clinical guidance, and diverse business solutions tailored for community-based oncology and other specialized medical practices. Furthermore, it offers pharmacies consulting, outsourcing, and technology services, alongside integrated financial, operational, and clinical solutions. The International segment extends its distribution network and comprehensive services to wholesale, institutional, and retail customers throughout 13 European nations and Canada. The Medical-Surgical Solutions division is devoted to providing healthcare providers with medical and surgical supply distribution, intricate logistics management, and supplementary services. The Prescription Technology Solutions (RxTS) segment is dedicated to resolving medication-related hurdles for patients across their entire treatment trajectory, working in partnership with biopharma and life sciences organizations. It also serves as a crucial link, connecting pharmacies, healthcare providers, payers, and biopharma companies to deploy cutting-edge solutions for enhancing medication access and adherence. Moreover, RxTS supplies robust third-party logistics and wholesale distribution assistance. Established in 1833, McKesson Corporation's corporate headquarters are situated in Irving, Texas.
IPO date
Nov 10, 1994
Employees
45,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT